114 related articles for article (PubMed ID: 28207101)
1. Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis.
Szturmowicz M; Tomkowski W; Fijalkowska A; Kupis W; Cieslik A; Demkow U; Langfort R; Wiechecka A; Orlowski T; Torbicki A
Int J Biol Markers; 2005; 20(1):43-49. PubMed ID: 28207101
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis.
Szturmowicz M; Tomkowski W; Fijalkowska A; Kupis W; Cieślik A; Demkow U; Langfort R; Wiechecka A; Orlowski T; Torbicki A
Int J Biol Markers; 2005; 20(1):43-9. PubMed ID: 15832772
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of malignant pericarditis: a single centre experience.
Pawlak Cieślik A; Szturmowicz M; Fijałkowska A; Gątarek J; Gralec R; Błasińska-Przerwa K; Szczepulska-Wójcik E; Skoczylas A; Bilska A; Tomkowski W
Kardiol Pol; 2012; 70(11):1147-53. PubMed ID: 23180523
[TBL] [Abstract][Full Text] [Related]
4. [Neoplastic pericarditis--the role of different diagnostic procedures].
Pawlak-Cieślik A; Szturmowicz M; Fijałkowska A; Tomkowski W; Kupis W; Langfort R; Demkow U; Wiechecka A; Orłowski T; Torbicki A
Pol Arch Med Wewn; 2006 Jan; 115(1):37-44. PubMed ID: 17278783
[TBL] [Abstract][Full Text] [Related]
5. The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis.
Szturmowicz M; Tomkowski W; Fijalkowska A; Burakowski J; Sakowicz A; Filipecki S
Int J Biol Markers; 1997; 12(3):96-101. PubMed ID: 9479590
[TBL] [Abstract][Full Text] [Related]
6. [Tumor markers in the assessment of malignant and benign pericardial effusion].
Karatolios K; Maisch B; Pankuweit S
Herz; 2011 Jun; 36(4):290-5. PubMed ID: 21491120
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of CYFRA 21-1 in malignant pleural effusion.
Dejsomritrutai W; Senawong S; Promkiamon B
Respirology; 2001 Sep; 6(3):213-6. PubMed ID: 11555379
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer.
Sharma SK; Bhat S; Chandel V; Sharma M; Sharma P; Gupta S; Sharma S; Bhat AA
J Carcinog; 2015; 14():7. PubMed ID: 26900349
[TBL] [Abstract][Full Text] [Related]
9. The value of the new scoring system for predicting neoplastic pericarditis in the patients with large pericardial effusion.
Szturmowicz M; Pawlak-Cieślik A; Fijałkowska A; Gątarek J; Skoczylas A; Dybowska M; Błasińska-Przerwa K; Langfort R; Tomkowski W
Support Care Cancer; 2017 Aug; 25(8):2399-2403. PubMed ID: 28258502
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
Lee JH; Chang JH
Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
[TBL] [Abstract][Full Text] [Related]
11. [The evaluation of carcinoembryonic antigen determination in the pericardial fluid in the diagnosis of the cause of pericarditis].
Szturmowicz M; Tomkowski W; Burakowski J; Fijałkowska A; Rogińska E; Sakowicz A; Filipecki S
Pol Merkur Lekarski; 1998 Jun; 4(24):306-8. PubMed ID: 9771011
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigens in the pericardial fluid of patients with malignant pericarditis.
Tatsuta M; Yamamura H; Yamamoto R; Ichii M; Iishi H; Noguchi S
Oncology; 1984; 41(5):328-30. PubMed ID: 6472769
[TBL] [Abstract][Full Text] [Related]
13. Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytologic results.
Antonangelo L; Sales RK; Corá AP; Acencio MM; Teixeira LR; Vargas FS
Curr Oncol; 2015 Oct; 22(5):e336-41. PubMed ID: 26628873
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.
Hsieh TC; Huang WW; Lai CL; Tsao SM; Su CC
Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492
[TBL] [Abstract][Full Text] [Related]
15. [Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers].
Karatolios K; Alter P; Maisch B
Herz; 2009 Dec; 34(8):624-33. PubMed ID: 20024642
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma.
Huang WW; Tsao SM; Lai CL; Su CC; Tseng CE
Pathology; 2010 Apr; 42(3):224-8. PubMed ID: 20350214
[TBL] [Abstract][Full Text] [Related]
17. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.
Shitrit D; Zingerman B; Shitrit AB; Shlomi D; Kramer MR
Oncologist; 2005 Aug; 10(7):501-7. PubMed ID: 16079317
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion.
Chen M; Xie S; Wan C; Zeng N; Wu Y; Qin J; Shen Y; Wen F
Postgrad Med; 2017 Aug; 129(6):644-648. PubMed ID: 28506100
[TBL] [Abstract][Full Text] [Related]
20. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
